Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Depreciation & Amortization (CF) (2020 - 2025)

Maxcyte (MXCT) has disclosed Depreciation & Amortization (CF) for 6 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) rose 1.42% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.3 million through Dec 2025, up 0.58% year-over-year, with the annual reading at $4.3 million for FY2025, 0.58% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $1.1 million at Maxcyte, roughly flat from $1.1 million in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $1.1 million in Q1 2024, with the low at $315900.0 in Q1 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $847360.0, with a median of $1.0 million recorded in 2023.
  • The sharpest move saw Depreciation & Amortization (CF) skyrocketed 120.82% in 2022, then dropped 4.08% in 2024.
  • Over 5 years, Depreciation & Amortization (CF) stood at $416500.0 in 2021, then surged by 120.82% to $919700.0 in 2022, then increased by 19.82% to $1.1 million in 2023, then dropped by 4.08% to $1.1 million in 2024, then rose by 1.42% to $1.1 million in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $1.1 million, $1.1 million, and $1.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.